On the contrary, reduced AMPK activity in WAT is linked to systemic insulin resistance in obese individuals, highlighting its pivotal role in NAFLD development (16, 17). This evidence concerns the gene PRKAA2 and metabolic dysfunction-associated steatotic liver disease.